Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Liu, Han  [Clear All Filters]
Journal Article
Yang J, Liu H, Sun H, Wang Z, Zhang R, Liu Y, Zhang Q, Zhang S, Zhang J, Shi C, et al. Construction of induced pluripotent stem cell line (ZZUi0017-A) from the fibroblast cells of a female patient with CACNA1A mutation by unintegrated reprogramming approach. Stem Cell Res. 2020;48:101946.
Khan MNoman, Wang B, Wei J, Zhang Y, Li Q, Luan X, Cheng J-W, Gordon JR, Li F, Liu H. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget. 2015.
Zaky MY, Liu X, Wang T, Wang S, Liu F, Wang D, Wu Y, Zhang Y, Guo D, Sun Q, et al. Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met. Arch Biochem Biophys. 2019:108239.
Wang T, Wang D, Zhang Y, Zhang J, Sun X, Wu Y, Wang S, Zhang Y, Xu L, Kong Q, et al. Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer. Int J Biochem Cell Biol. 2018.
Li W, Tamamura R, Wang B, Liu Q, Liu H, Liu T, Katase N, Xiao J, Nagatsuka H. Expressions of ABCG2, CD133, and Podoplanin in Salivary Adenoid Cystic Carcinoma. Biomed Res Int. 2014;2014:132349.
Fan Y, Liu F, Fan L-Y, Mao C-Y, Liu H, Zhang C, Yuan Y-P, Yang J, Wang Y-L, Liu Y-T, et al. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene. Stem Cell Res. 2021;52:102257.
Wang Y, Sun H, Wang Z, Yue Y, Zhang R, Yang J, Liu Y, Liu H, Zhang Q, Zhang S, et al. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3. Stem Cell Res. 2019;41:101564.
Gao Y, Wang Y, Wang Z, Sun H, Zhang R, Yang J, Liu Y, Liu H, Zhang Q, Zhang S, et al. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human. Stem Cell Res. 2020;43:101717.
Wang Z, Sun H, Zhang Q, Yang J, Liu Y, Liu H, Shi C, Wang Y, Xu Y. Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease. Stem Cell Res. 2021;53:102267.
Wang Y, Sun H, Wang Z, Zhang Q, Yang J, Liu Y, Liu H, Shi C, Wang Y, Xu Y. Generation of induced pluripotent stem cell line (ZZUi019-A) derived from skin fibroblasts from a healthy volunteer. Stem Cell Res. 2021;53:102285.
Wang Y, Wang Z, Sun H, Shi C, Yang J, Liu Y, Liu H, Zhang S, Zhang L, Xu Y, et al. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1. Stem Cell Res. 2018;32:61-64.
Liu H, Du L, Wang R, Wei C, Liu B, Zhu L, Liu P, Liu Q, Li J, Lu S-L, et al. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy. Oncotarget. 2015.
Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q, Chen C, Qi Y, Gao W, He W, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021.
Jiang K, Liu M, Lin G, Mao B, Cheng W, Liu H, Gal J, Zhu H, Yuan Z, Deng W, et al. Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death. Oncotarget. 2016.